These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 39167154)

  • 1. Antimicrobial resistance: use of phage therapy in the management of resistant infections.
    Ikpe F; Williams T; Orok E; Ikpe A
    Mol Biol Rep; 2024 Aug; 51(1):925. PubMed ID: 39167154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial effect of phage cocktails and phage-antibiotic synergy against pathogenic
    Zhao M; Li H; Gan D; Wang M; Deng H; Yang QE
    mSystems; 2024 Sep; 9(9):e0060724. PubMed ID: 39166877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage therapy: an alternative treatment modality for MDR bacterial infections.
    Pal N; Sharma P; Kumawat M; Singh S; Verma V; Tiwari RR; Sarma DK; Nagpal R; Kumar M
    Infect Dis (Lond); 2024 Oct; 56(10):785-817. PubMed ID: 39017931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential use of bacteriophages as antibacterial agents against Klebsiella pneumoniae.
    Gholizadeh O; Ghaleh HEG; Tat M; Ranjbar R; Dorostkar R
    Virol J; 2024 Aug; 21(1):191. PubMed ID: 39160541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage Resistance in Multidrug-Resistant Klebsiella pneumoniae ST258 Evolves via Diverse Mutations That Culminate in Impaired Adsorption.
    Hesse S; Rajaure M; Wall E; Johnson J; Bliskovsky V; Gottesman S; Adhya S
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary Rationale for Phages as Complements of Antibiotics.
    Torres-Barceló C; Hochberg ME
    Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel phage against multidrug-resistant Klebsiella pneumoniae.
    Yang L; Wang C; Zeng Y; Song Y; Zhang G; Wei D; Li Y; Feng J
    Arch Microbiol; 2024 Aug; 206(9):379. PubMed ID: 39143367
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Li S; Wei B; Xu L; Cong C; Murtaza B; Wang L; Li X; Li J; Xu M; Yin J; Xu Y
    J Virol; 2024 Jul; 98(7):e0046724. PubMed ID: 38864621
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles.
    Teymouri S; Pourhajibagher M; Bahador A
    Mol Biol Rep; 2024 Oct; 51(1):1044. PubMed ID: 39377967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans.
    El Haddad L; Harb CP; Gebara MA; Stibich MA; Chemaly RF
    Clin Infect Dis; 2019 Jun; 69(1):167-178. PubMed ID: 30395179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophages as a potential substitute for antibiotics: A comprehensive review.
    Kushwaha SO; Sahu SK; Yadav VK; Rathod MC; Patel D; Sahoo DK; Patel A
    Cell Biochem Funct; 2024 Apr; 42(3):e4022. PubMed ID: 38655589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens.
    Plumet L; Costechareyre D; Lavigne J-P; Kissa K; Molle V
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0082924. PubMed ID: 39248472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258.
    Hesse S; Malachowa N; Porter AR; Freedman B; Kobayashi SD; Gardner DJ; Scott DP; Adhya S; DeLeo FR
    mBio; 2021 Feb; 12(1):. PubMed ID: 33622728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage Therapy: An Alternative Approach to Combating Multidrug-Resistant Bacterial Infections in Cystic Fibrosis.
    Cocorullo M; Stelitano G; Chiarelli LR
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing bacteriophage treatment of resistant
    Ulrich L; Steiner LX; Giez C; Lachnit T
    mSphere; 2024 Jul; 9(7):e0070723. PubMed ID: 38934592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A game of resistance: War between bacteria and phages and how phage cocktails can be the solution.
    Costa P; Pereira C; Romalde JL; Almeida A
    Virology; 2024 Nov; 599():110209. PubMed ID: 39186863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of
    Tan D; Zhang Y; Cheng M; Le S; Gu J; Bao J; Qin J; Guo X; Zhu T
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31752386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.